Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 15, Issue 8, Pages 533-550
Publisher
Springer Nature
Online
2016-04-07
DOI
10.1038/nrd.2016.29
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small-molecule inhibitors of the Myc oncoprotein
- (2015) Steven Fletcher et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Flexibility and small pockets at protein–protein interfaces: New insights into druggability
- (2015) Harry Jubb et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Rational design of protein–protein interaction inhibitors
- (2015) Didier Rognan MedChemComm
- Towards understanding cell penetration by stapled peptides
- (2015) Qian Chu et al. MedChemComm
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- Small-Molecule Inhibitors That Target Protein-Protein Interactions in the RAD51 Family of Recombinases
- (2014) Duncan E. Scott et al. ChemMedChem
- Structure-based design of small-molecule protein–protein interaction modulators: the story so far
- (2014) Federico Falchi et al. Future Medicinal Chemistry
- The Use of Chlorobenzene as a Probe Molecule in Molecular Dynamics Simulations
- (2014) Yaw Sing Tan et al. Journal of Chemical Information and Modeling
- Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
- (2014) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
- (2014) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
- (2014) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress
- (2014) Loren D. Walensky et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
- (2013) Douglas Marcotte et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
- (2013) Longqin Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Using a Fragment-Based Approach To Target Protein-Protein Interactions
- (2013) Duncan E. Scott et al. CHEMBIOCHEM
- Fragment-based hit identification: thinking in 3D
- (2013) Andrew D. Morley et al. DRUG DISCOVERY TODAY
- Design and Synthesis of a Prototype Scaffold for Five-Residue α-Helix Mimetics
- (2013) Andrew R. Bayly et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
- (2013) Olivier Mirguet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain
- (2013) Robert F. Kester et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain
- (2013) Andrew F. Donnell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins
- (2013) Yuta Tanaka et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
- (2013) Gunther Zimmermann et al. NATURE
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- The 'rule of three' for fragment-based drug discovery: where are we now?
- (2013) Harren Jhoti et al. NATURE REVIEWS DRUG DISCOVERY
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction with improved binding and cellular activity
- (2013) Rowena Hancock et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Predicting where Small Molecules Bind at Protein-Protein Interfaces
- (2013) Peter Walter et al. PLoS One
- Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
- (2013) Tim J. Blackburn et al. MedChemComm
- Novel protein–protein interaction inhibitor of Nrf2–Keap1 discovered by structure-based virtual screening
- (2013) Hao-Peng Sun et al. MedChemComm
- Deconstruction of a Nutlin: Dissecting the Binding Determinants of a Potent Protein–Protein Interaction Inhibitor
- (2013) David C. Fry et al. ACS Medicinal Chemistry Letters
- Druggable Protein Interaction Sites Are More Predisposed to Surface Pocket Formation than the Rest of the Protein Surface
- (2013) David K. Johnson et al. PLoS Computational Biology
- Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
- (2012) Heidi L. Perez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- The Future of Peptide-based Drugs
- (2012) David J. Craik et al. Chemical Biology & Drug Design
- Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface
- (2012) Inge Van Molle et al. CHEMISTRY & BIOLOGY
- Computational Drug Design Targeting Protein-Protein Interactions
- (2012) Rachelle J. Bienstock CURRENT PHARMACEUTICAL DESIGN
- Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity
- (2012) Matthew C. Smith et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Design of Bcl-2 and Bcl-xL Inhibitors with Subnanomolar Binding Affinities Based upon a New Scaffold
- (2012) Haibin Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction
- (2012) Hacer Karatas et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structure-based prediction of protein–protein interactions on a genome-wide scale
- (2012) Qiangfeng Cliff Zhang et al. NATURE
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- 2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions
- (2012) Marie Jeanne Basse et al. NUCLEIC ACIDS RESEARCH
- Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design
- (2012) Thomas S. Peat et al. PLoS One
- Biophysical and computational fragment-based approaches to targeting protein–protein interactions: applications in structure-guided drug discovery
- (2012) Anja Winter et al. QUARTERLY REVIEWS OF BIOPHYSICS
- From Crystal Packing to Molecular Recognition: Prediction and Discovery of a Binding Site on the Surface of Polo-Like Kinase 1
- (2011) Paweł Śledź et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dr. PIAS: an integrative system for assessing the druggability of protein-protein interactions
- (2011) Nobuyoshi Sugaya et al. BMC BIOINFORMATICS
- Comprehensive, atomic-level characterization of structurally characterized protein-protein interactions: the PICCOLO database
- (2011) George R Bickerton et al. BMC BIOINFORMATICS
- Kinetic Analyses of Keap1-Nrf2 Interaction and Determination of the Minimal Nrf2 Peptide Sequence Required for Keap1 Binding Using Surface Plasmon Resonance
- (2011) Yu Chen et al. Chemical Biology & Drug Design
- Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)
- (2011) Xavier Morelli et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
- (2011) Rowena Hancock et al. FREE RADICAL BIOLOGY AND MEDICINE
- Emerging role of surface plasmon resonance in fragment-based drug discovery
- (2011) Iva Navratilova et al. Future Medicinal Chemistry
- Thermodynamic Properties of Water Molecules at a Protein–Protein Interaction Surface
- (2011) David J. Huggins et al. Journal of Chemical Theory and Computation
- A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
- (2011) Qian Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Screening Multicomponent Reactions for X-Linked Inhibitor of Apoptosis-Baculoviral Inhibitor of Apoptosis Protein Repeats Domain Binder
- (2011) Ilaria Monfardini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity
- (2011) Brad E. Sleebs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Compound Design by Fragment-Linking
- (2011) Osamu Ichihara et al. Molecular Informatics
- Inhibition of bromodomain-mediated protein–protein interactions as a novel therapeutic strategy
- (2011) Silviya D. Furdas et al. MedChemComm
- Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic Inhibitors
- (2010) Andrea L. Jochim et al. ACS Chemical Biology
- Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
- (2010) Bonsu Ku et al. CELL RESEARCH
- Update 1 of: Beta-Strand Mimetics
- (2010) Wendy A. Loughlin et al. CHEMICAL REVIEWS
- Drugging challenging targets using fragment-based approaches
- (2010) Anthony G Coyne et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Targeting the BH3 Domain Mediated Protein−Protein Interaction of Bcl-xL through Virtual Screening
- (2010) Prasenjit Mukherjee et al. Journal of Chemical Information and Modeling
- Fragment-Based Deconstruction of Bcl-xLInhibitors
- (2010) Sarah Barelier et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Magic bullets in nature's arsenal
- (2010) Joshua A Kritzer Nature Chemical Biology
- Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
- (2010) Frauke Christ et al. Nature Chemical Biology
- The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
- (2010) Michelle L Stewart et al. Nature Chemical Biology
- Integrins as therapeutic targets: lessons and opportunities
- (2010) Dermot Cox et al. NATURE REVIEWS DRUG DISCOVERY
- The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
- (2010) D. Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discovery
- (2010) L. M. C. Meireles et al. NUCLEIC ACIDS RESEARCH
- The Overlap of Small Molecule and Protein Binding Sites within Families of Protein Structures
- (2010) Fred P. Davis et al. PLoS Computational Biology
- High-Resolution Structural Characterization of a Helical α/β-Peptide Foldamer Bound to the Anti-Apoptotic Protein Bcl-xL
- (2009) Erinna F. Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Atomic Interactions and Profile of Small Molecules Disrupting Protein-Protein Interfaces: the TIMBAL Database
- (2009) Alícia P. Higueruelo et al. Chemical Biology & Drug Design
- Picking up the pieces with FBDD or FADD: invest early for future success
- (2009) Mark Whittaker DRUG DISCOVERY TODAY
- Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands
- (2009) Erinna F. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction
- (2009) John G. Allen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of an α-Helix Mimetic Library Targeting Protein−Protein Interactions
- (2009) Alex Shaginian et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
- (2009) Dalia I. Hammoudeh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- β-Peptidic Peptidomimetics
- (2008) Dieter Seebach et al. ACCOUNTS OF CHEMICAL RESEARCH
- Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
- (2008) Federica Cossu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
- (2008) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- Principles of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?
- (2008) Ozlem Keskin et al. CHEMICAL REVIEWS
- Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules
- (2008) Ariele Viacava Follis et al. CHEMISTRY & BIOLOGY
- Contemporary strategies for the stabilization of peptides in the α-helical conformation
- (2008) Laura K Henchey et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Predicting druggable binding sites at the protein–protein interface
- (2008) Jonathan C. Fuller et al. DRUG DISCOVERY TODAY
- Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide
- (2008) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex
- (2008) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors
- (2008) Jui-Wen Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Atomic Structure of a Short α-Helix Stabilized by a Main Chain Hydrogen-Bond Surrogate
- (2008) Jie Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started